The 3rd Pharmacovigilance, Risk Management, & Adverse Event Reporting 2013 covers topics such as:
- Drug safety and risk management strategies
- Global regulations regarding drug safety and the proper reporting of adverse events
- Strategies regarding REMS and singal detection to strenghten existing internal procedures
- Techniques to best protect the company from adverse events and ensure compliance if they do not occur
- Overcome challenges in post-marketing safety and in specific to clinical safety
The 3rd Pharmacovigilance, Risk Management, & Adverse Event Reporting 2013 brings together:
- Drug Safety/Risk Management
- Pharmacovigilance
- Drug/Product Safety
- Pharmacoepidemiology
- Signal Detection
- REMS
- Patient/Medical Safety
- Clinical Safety
- Phase IV/Post Marketing Studies
- Safety Surveillance
- Medical Directors
